Low serum pseudocholinesterase levels are associated with mortality in patients with hepatocellular carcinoma
PCHE is a reliable stand-alone biomarker of HCC prognosis. It is an independent predictor of mortality and can improve the accuracy of existing scoring systems. Improved risk stratification could improve outcomes by informing treatment decisions regarding hepatectomy or other interventions.
Authors
- Kirk J. Wangensteen (ORCID: https://orcid.org/0000-0001-6042-6490)
- Marie-Lise Chrysostome
- Lewis R. Roberts (ORCID: https://orcid.org/0000-0001-7885-8574)
- Sumera Ilyas
- H. K. Miller
- Perapa Chotiprasidhi
- Karina Sato-Espinoza
- Robert A. Vierkant
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1097/hc9.0000000000000879
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00